Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             693 results found
no title author magazine year volume issue page(s) type
1 AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions Klasen, Benedikt
112-113 C p. 80-93
 article
2 A brief history of the Society of Radiopharmaceutical Sciences Coenen, Heinz H.
112-113 C p. 31-34
 article
3 Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology Fassbender, Thomas F.
 2019
 112-113 C p. 32-38
 article
4 A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models Ferguson, Simon
112-113 C p. 74-83
 article
5 A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models Zhang-Yin, Jules
112-113 C p. 88-95
 article
6 A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts Cho, Hyungjun
112-113 C p. 11-19
 article
7 Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target Matyskin, Artem V.
112-113 C p.
 article
8 Adaptation of a commercially available module for the production of alpha-[11C]methyl-L-tryptophan ([11C]AMT) for human use Bamminger, Karsten
112-113 C p.
 article
9 A decade of ubiquicidin development for PET imaging of infection: A systematic review Marjanovic-Painter, Biljana
112-113 C p.
 article
10 Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases Dyer, Michael R.
112-113 C p.
 article
11 Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy Mortensen, Anja Charlotte Lundgren
112-113 C p.
 article
12 A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3 Man, Francis
112-113 C p. 31-40
 article
13 Alanine and glycine conjugates of (2S,4R)-4-[18F]fluoroglutamine for tumor imaging Zha, Zhihao
 2018
 112-113 C p. 19-28
 article
14 Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation Alonso Martinez, Luis Michel
 2018
 112-113 C p. 36-42
 article
15 Alkaline degradation of lyophilized DMSA prior to labeling with 99mTc: Identification and development of the degradation pathway by HPLC and MS Almeida, Erika V.
 2018
 112-113 C p. 20-27
 article
16 Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy Tosato, Marianna
112-113 C p.
 article
17 Alpha emitting nuclides for targeted therapy Hatcher-Lamarre, Jasmine L.
112-113 C p. 228-240
 article
18 Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors Maina, Theodosia
 2017
 112-113 C p. 57-62
6 p.
 article
19 A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor Petrulli, J. Ryan
 2017
 112-113 C p. 56-61
 article
20 An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT) Baimukhanova, Ayagoz
112-113 C p. 35-43
 article
21 An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation Chakravarty, Rubel
 2018
 112-113 C p. 8-19
 article
22 An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications Forrester, Ryan
112-113 C p.
 article
23 A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter Vraka, Chrysoula
 2018
 112-113 C p. 29-36
 article
24 An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges Bogni, A.
 2019
 112-113 C p. 11-19
 article
25 An original radio-biomimetic approach to synthesize radiometabolites for PET imaging Auvity, Sylvain
112-113 C p. 10-14
 article
26 A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation Tekin, Volkan
112-113 C p. 20-31
 article
27 A novel synergistic drug combination of a mitogen-activated extracellular signal-regulated kinase inhibitor with [177Lu]Lu-rhPSMA-10.1 for prostate cancer treatment: Results of a preclinical evaluation Foxton, Caroline
112-113 C p.
 article
28 Antimicrobial peptide LyeTx I mn∆K labeled with 68Ga is a potential PET radiopharmaceutical for molecular imaging of infections Fuscaldi, Leonardo Lima
112-113 C p.
 article
29 Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping Tada, Tetsuro
112-113 C p.
 article
30 Application of [99mTc]Tc-GSA in the diagnosis of Staphylococcus aureus infections Mizutani, Asuka
112-113 C p.
 article
31 Applying radiobiology to clinical molecular radiotherapy Murray, Iain
112-113 C p. 1-3
 article
32 Approaches to improve metabolic stability of a statine-based GRP receptor antagonist Popp, Ilinca
 2017
 112-113 C p. 22-29
8 p.
 article
33 A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator Jang, Jaewoong
112-113 C p. 1-9
 article
34 A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy Destro, Gianluca
112-113 C p.
 article
35 A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo Tang, Yu
 2019
 112-113 C p. 23-31
 article
36 A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals Sharma, Sai Kiran
 2019
 112-113 C p. 32-38
 article
37 A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept Chen, Wen
112-113 C p. 107-114
 article
38 A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications Mastren, Tara
112-113 C p. 69-73
 article
39 Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe Mizuno, Yuki
112-113 C p. 30-36
 article
40 A simple device to convert a small-animal PET scanner into a multi-sample tissue and injection syringe counter Green, Michael V.
 2017
 112-113 C p. 9-13
5 p.
 article
41 A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain Kilbourn, Michael R.
 2017
 112-113 C p. 34-37
 article
42 Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging Singh, Nisha
 2018
 112-113 C p. 32-39
 article
43 Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid Kobayashi, Masato
112-113 C p. 92-97
 article
44 Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3+ Kelly, James M.
 2017
 112-113 C p. 38-46
 article
45 Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer Michalski, Kerstin
112-113 C p. 37-43
 article
46 Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation Choi, Jaeyeon
 2018
 112-113 C p. 10-20
 article
47 Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy Ogawa, Kazuma
112-113 C p.
 article
48 A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation Feng, Yutian
112-113 C p.
 article
49 211At labeled substance P (5–11) as potential radiopharmaceutical for glioma treatment Lyczko, Monika
 2017
 112-113 C p. 1-8
8 p.
 article
50 A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability Feng, Yutian
 2018
 112-113 C p. 1-10
 article
51 Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy Madsen, Karina Lindbøg
112-113 C p. 35-40
 article
52 Auger: The future of precision medicine Pirovano, Giacomo
112-113 C p. 50-53
 article
53 A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus Kawamura, Kazunori
 2017
 112-113 C p. 1-7
7 p.
 article
54 Automated production of [11C]butyrate for keto body PET imaging Pakula, Ryan J.
112-113 C p.
 article
55 Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors Lindner, Simon
112-113 C p. 86-95
 article
56 Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors Huang, Shun
112-113 C p. 64-71
 article
57 Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET Ramakrishnan, Nisha K.
112-113 C p. 71-77
 article
58 Automated radiosynthesis of 5-[11C]l-glutamine, an important tracer for glutamine utilization Rosenberg, Adam J.
 2018
 112-113 C p. 10-14
 article
59 Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo Wichmann, Christian W.
112-113 C p.
 article
60 Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans Caillé, Fabien
112-113 C p. 20-27
 article
61 Automation of simplified two-step radiolabeling via ditosylate synthon for 18F-labeled radiotracers using AllinOne module Li, Shihong
112-113 C p.
 article
62 Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images Cysouw, Matthijs C.F.
 2017
 112-113 C p. 18-24
7 p.
 article
63 B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models Kasten, Benjamin B.
 2017
 112-113 C p. 23-30
 article
64 Biodistribution and long-term toxicity of neutron-activated Samarium-153 oxide-loaded polystyrene microspheres in healthy rats Tan, Hun Yee
112-113 C p.
 article
65 Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers Yang, Qiao
112-113 C p. 32-37
 article
66 Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies Doot, Robert K.
112-113 C p. 1-8
 article
67 Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study Sato, Kengo
112-113 C p.
 article
68 Biodistribution study of 211Pb progeny released from intravenously applied 223Ra labelled TiO2 nanoparticles in a mouse model Sakmár, Michal
112-113 C p.
 article
69 Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles Pérez-Velasco, Diana L.
112-113 C p.
 article
70 Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78 Yao, Bolin
112-113 C p.
 article
71 Biologicals as theranostic vehicles in paediatric oncology Niessen, Veerle J.A.
112-113 C p. 58-64
 article
72 Bismuth chelation for targeted alpha therapy: Current state of the art Franchi, Sara
112-113 C p. 168-188
 article
73 Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(l-lactic acid) microspheres Bakker, Robbert C.
 2019
 112-113 C p. 11-18
 article
74 BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain van der Wildt, Berend
112-113 C p. 44-51
 article
75 Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging Fukakusa, Shota
112-113 C p.
 article
76 Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents Ogata, Aya
112-113 C p. 52-58
 article
77 Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety Hu, Kun
 2017
 112-113 C p. 43-50
8 p.
 article
78 Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d 2: A comparison with [18F]FDG Oh, Chiwoo
112-113 C p. 98-103
 article
79 Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors Vaidyanathan, Ganesan
112-113 C p. 18-30
 article
80 Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam Mastren, Tara
 2017
 112-113 C p. 24-29
 article
81 Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis Meletta, Romana
 2017
 112-113 C p. 31-43
 article
82 Carbon-11-labelling of the histone deacetylase 6 radioligand EKZ-001 Tago, Tetsuro
112-113 C p.
 article
83 [11C]AZ10419096 – a full antagonist PET radioligand for imaging brain 5-HT1B receptors Lindberg, Anton
 2017
 112-113 C p. 34-40
7 p.
 article
84 Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer Su, Shu
112-113 C p. 76-83
 article
85 Cerebral and myocardial kinetics of [11C]acetoacetate and [11C]β-hydroxybutyrate: A comparative crossover study in healthy rats Kjærulff, Mette Louise Gram
112-113 C p.
 article
86 [11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice Traxl, Alexander
 2017
 112-113 C p. 7-15
9 p.
 article
87 Characterization of actinide resin for separation of 51,52gMn from bulk target material Barrett, Kendall E.
112-113 C p. 19-26
 article
88 Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate Xu, Yulong
112-113 C p.
 article
89 Characterization of a S1PR2 specific 11C-labeled radiotracer in streptozotocin-induced diabetic murine model Jiang, Hao
112-113 C p.
 article
90 Chelation chemistry of manganese-52 for PET imaging applications Omweri, James M.
112-113 C p.
 article
91 Chemokine receptor PET imaging: Bridging molecular insights with clinical applications Hunter, Chanelle
112-113 C p.
 article
92 Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours Gaertner, F.C.
112-113 C p. 1-9
 article
93 Clinical 68Ga-PET: Is radiosynthesis module an absolute necessity? Chakravarty, Rubel
 2017
 112-113 C p. 1-11
11 p.
 article
94 Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer Evangelista, Laura
 2017
 112-113 C p. 47-49
 article
95 Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy Chakravarty, Rubel
 2019
 112-113 C p. 1-10
 article
96 Clinical translation of a PSMA inhibitor for 99mTc-based SPECT Ferro-Flores, Guillermina
 2017
 112-113 C p. 36-44
9 p.
 article
97 Clinical usefulness of 18F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis Lefebvre, Nicolas
 2017
 112-113 C p. 17-24
 article
98 Combination radionuclide therapy: A new paradigm Suman, Shishu Kant
112-113 C p. 40-58
 article
99 Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo Höffgen, Katharina S.
112-113 C p.
 article
100 Commentary Eckelman, William C.
 2017
 112-113 C p. 1-3
3 p.
 article
101 Comparative evaluation of [18F]DiFA and its analogs as novel hypoxia positron emission tomography and [18F]FMISO as the standard Nakata, Norihito
 2019
 112-113 C p. 39-45
 article
102 Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model Grzmil, Michal
112-113 C p.
 article
103 Comparison between [18F]fluorination and [18F]fluoroethylation reactions for the synthesis of the PDE10A PET radiotracer [18F]MNI-659 Mori, Wakana
 2017
 112-113 C p. 12-18
 article
104 Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches Feiner, Irene V.J.
112-113 C p. 24-33
 article
105 Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold Kaeopookum, Piriya
112-113 C p. 1-10
 article
106 Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model Green, Michael V.
 2017
 112-113 C p. 29-36
8 p.
 article
107 Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA) Chang, Ting-Yu
112-113 C p.
 article
108 Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells Garg, Ravendra
112-113 C p. 80-88
 article
109 Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation Krohn, Kenneth A.
112-113 C p. 5-23
 article
110 Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight Coenen, Heinz H.
 2017
 112-113 C p. v-xi
 article
111 Contents
112-113 C p. OBC
 article
112 Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies Amor-Coarasa, Alejandro
 2017
 112-113 C p. 37-39
3 p.
 article
113 Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue Parente, Andrea
 2017
 112-113 C p. 50-56
 article
114 Co-production of 155Tb and 152Tb irradiating 155Gd / 151Eu tandem target with a medium energy α-particle beam Moiseeva, A.N.
112-113 C p.
 article
115 Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy? Chia, Kazumi
112-113 C p. 10-17
 article
116 Corrigendum to “Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy” [Nucl Med Biol (March–April 2025) 108990] Tosato, Marianna
112-113 C p.
 article
117 Corrigendum to “131I-labeled chitosan hydrogels for radioembolization: a preclinical study in small animals” [Nucl Med Biol 52 (2017) 16–23] Hwang, Hyosook
 2018
 112-113 C p. 50
 article
118 Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73] Kasten, Benjamin B.
 2018
 112-113 C p. 71
 article
119 Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011] Tournier, Benjamin B.
112-113 C p.
 article
120 Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] Stergiou, N.
112-113 C p. 65
 article
121 [11C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain Vidal, Benjamin
 2017
 112-113 C p. 1-6
 article
122 [11C]phosgene: Synthesis and application for development of PET radiotracers Fukumura, Toshimitsu
112-113 C p. 138-148
 article
123 Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV Sinharay, Sanhita
 2017
 112-113 C p. 27-33
 article
124 Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production Lebeda, Ondřej
112-113 C p.
 article
125 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route Nelson, Bryce J.B.
112-113 C p.
 article
126 Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology Stegmayr, Carina
112-113 C p. 78-84
 article
127 Cyclotron production of 68Ga in a liquid target: Effects of solution composition and irradiation parameters Pandey, Mukesh K.
112-113 C p. 49-55
 article
128 Cyclotron production of 99mTc Gumiela, Magdalena
 2018
 112-113 C p. 33-41
 article
129 Cyclotron production of 103Pd using a liquid target Krol, Viktoria
112-113 C p.
 article
130 Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT Jiang, Donglang
112-113 C p. 89-95
 article
131 Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters Rosenkranz, Andrey A.
112-113 C p. 45-56
 article
132 Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11 Svedjehed, Johan
112-113 C p. 1-10
 article
133 Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue Goos, Jeroen A.C.M.
112-113 C p. 63-72
 article
134 Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors Lever, John R.
 2019
 112-113 C p. 53-66
 article
135 Detection of melanoma metastases with PET—Comparison of 18F-5-FPN with 18F–FDG Wang, Yichun
 2017
 112-113 C p. 33-38
 article
136 Deuterated [18F]fluoroethyl tropane analogs as dopamine transporter probes: Synthesis and biological evaluation Li, Qingming
112-113 C p.
 article
137 Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent Liu, Futao
 2018
 112-113 C p. 42-49
 article
138 Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a) Kawamura, Kazunori
 2017
 112-113 C p. 49-56
8 p.
 article
139 Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2 Ma, Li
112-113 C p. 61-69
 article
140 Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications Klasen, Benedikt
112-113 C p. 12-23
 article
141 Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations Radzik, Marcin
112-113 C p. 63-73
 article
142 Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapy Ondrák, Lukáš
112-113 C p.
 article
143 Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET Zhang, Xiaohui
112-113 C p.
 article
144 Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096 Lindberg, Anton
112-113 C p. 11-16
 article
145 Development of a novel radiobromine-labeled sigma-1 receptor imaging probe Ogawa, Kazuma
 2018
 112-113 C p. 28-35
 article
146 Development of a PET radioligand selective for cerebral amyloid angiopathy Abrahamson, Eric E.
112-113 C p. 85-96
 article
147 Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At Crawford, Jason R.
 2017
 112-113 C p. 31-35
5 p.
 article
148 Development of a thin layer chromatography method for plasma correction of [18F]fluorocholine metabolites in positron emission tomography quantification studies in humans Villar, Marina
112-113 C p. 34-40
 article
149 Development of [11C]/[3H]THK-5351 – A potential novel carbon-11 tau imaging PET radioligand Stepanov, Vladimir
 2017
 112-113 C p. 50-53
4 p.
 article
150 Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands Bongarzone, Salvatore
 2019
 112-113 C p. 14-21
 article
151 Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase van der Wildt, Berend
 2017
 112-113 C p. 90-104
15 p.
 article
152 Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes Saito, Kosuke
112-113 C p. 72-79
 article
153 Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma Zhu, Wen Jing
 2018
 112-113 C p. 16-21
 article
154 Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers Kumar, Dheeraj
112-113 C p. 1-10
 article
155 Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates Stepanov, Vladimir
 2018
 112-113 C p. 12-19
 article
156 (1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection de Sousa Lacerda, Camila Maria
 2017
 112-113 C p. 19-24
6 p.
 article
157 Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells Kobayashi, Masato
 2017
 112-113 C p. 78-82
5 p.
 article
158 Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist Ahenkorah, Stephen
112-113 C p.
 article
159 Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation Wang, Jing
112-113 C p. 46-52
 article
160 Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain van der Wildt, Berend
112-113 C p. 99-107
 article
161 Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold He, Yingfang
112-113 C p. 24-32
 article
162 Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy Bastiani, Isabella
112-113 C p. 10-20
 article
163 Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system Matesic, Lidia
 2017
 112-113 C p. 24-31
8 p.
 article
164 DOTA-tetrazine probes with modified linkers for tumor pretargeting Läppchen, Tilman
 2017
 112-113 C p. 19-26
 article
165 Do we say what we mean and mean what we say? Coenen, Heinz H.
 2017
 112-113 C p. 53-54
2 p.
 article
166 Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer Staniszewska, Magdalena
112-113 C p. 101-111
 article
167 Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours Knight, James C.
 2019
 112-113 C p. 14-22
 article
168 Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs de Lange, Charlotte
 2018
 112-113 C p. 49-57
 article
169 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
170 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
171 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
172 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
173 Editorial Board
112-113 C p. ii
 article
174 Editorial Board
112-113 C p. ii
 article
175 Editorial Board
112-113 C p. ii
 article
176 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
177 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
178 Editorial Board 2018
 112-113 C p. IFC
 article
179 Editorial Board 2018
 112-113 C p. IFC
 article
180 Editorial Board 2018
 112-113 C p. IFC
 article
181 Editorial Board
112-113 C p. IFC
 article
182 Editorial Board
112-113 C p. IFC
 article
183 Editorial Board 2017
 112-113 C p. IFC
 article
184 Editorial Board 2017
 112-113 C p. IFC
 article
185 Editorial Board 2017
 112-113 C p. IFC
 article
186 Editorial Board 2018
 112-113 C p. IFC
 article
187 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
188 Editorial Board 2017
 112-113 C p. IFC-
1 p.
 article
189 Editorial Board 2017
 112-113 C p. IFC
 article
190 Editorial Board 2018
 112-113 C p. IFC
 article
191 Editorial Board 2018
 112-113 C p. IFC
 article
192 Editorial Board 2019
 112-113 C p. ii
 article
193 Editorial Board 2018
 112-113 C p. IFC
 article
194 Editorial Board 2018
 112-113 C p. IFC
 article
195 Editorial Board 2019
 112-113 C p. ii
 article
196 Editorial Board 2019
 112-113 C p. ii
 article
197 Editorial Board 2019
 112-113 C p. ii
 article
198 Editorial Board
112-113 C p. ii
 article
199 Editorial Board
112-113 C p. ii
 article
200 Editorial Board
112-113 C p. ii
 article
201 Editorial Board
112-113 C p. ii
 article
202 Editorial Board
112-113 C p. ii
 article
203 Editorial Board
112-113 C p. ii
 article
204 Editorial Board
112-113 C p. ii
 article
205 Editorial Board
112-113 C p. ii
 article
206 Editorial Board
112-113 C p. ii
 article
207 Editorial Board
112-113 C p. ii
 article
208 Editorial Board
112-113 C p. ii
 article
209 Editorial Board
112-113 C p. ii
 article
210 Editorial Board
112-113 C p. ii
 article
211 Editorial Board
112-113 C p. ii
 article
212 Editorial Board
112-113 C p. ii
 article
213 Editorial Board
112-113 C p. ii
 article
214 Editorial Board
112-113 C p. ii
 article
215 Editorial Board
112-113 C p.
 article
216 Editorial Board
112-113 C p.
 article
217 Editorial Board
112-113 C p.
 article
218 Editorial Board
112-113 C p. ii
 article
219 Editorial Board
112-113 C p.
 article
220 Editorial Board
112-113 C p. ii
 article
221 Editorial Board
112-113 C p.
 article
222 Editorial Board
112-113 C p.
 article
223 Editorial Board
112-113 C p.
 article
224 Editorial Board
112-113 C p.
 article
225 Editorial Board
112-113 C p.
 article
226 Editorial Board
112-113 C p.
 article
227 Editorial Board
112-113 C p.
 article
228 Editorial Board
112-113 C p.
 article
229 Editorial Board
112-113 C p.
 article
230 Editorial Board
112-113 C p.
 article
231 Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR Chan, Conrad
112-113 C p. 37-44
 article
232 Effect of methoxy group position on biological properties of 18F–labeled benzyl triphenylphosphonium cations Chen, Shuting
 2017
 112-113 C p. 16-23
 article
233 Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE Rousseau, Etienne
 2018
 112-113 C p. 10-17
 article
234 Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands Tago, Tetsuro
112-113 C p. 38-45
 article
235 Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation Keinänen, Outi
 2018
 112-113 C p. 27-35
 article
236 Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid Kanai, Ayaka
112-113 C p. 47-52
 article
237 Enhancing the therapeutic index of [211At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands Huynh, Truc T.
112-113 C p.
 article
238 Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe Hamamatsu, Keita
112-113 C p. 22-27
 article
239 Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer Green, Mark A.
 2017
 112-113 C p. 32-35
4 p.
 article
240 Evaluation and selection of a lead diabody for interferon-γ PET imaging Rezazadeh, Farzaneh
112-113 C p. 162-167
 article
241 Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen Lewis, Michael R.
112-113 C p.
 article
242 Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma Cortez, Angel
112-113 C p. 62-72
 article
243 Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin Graves, Stephen A.
112-113 C p. 1-7
 article
244 Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine? Guleria, Mohini
112-113 C p.
 article
245 Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and 177Lu labeling Altai, Mohamed
 2017
 112-113 C p. 1-9
9 p.
 article
246 Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26 Mansour, Nematallah
 2018
 112-113 C p. 31-38
 article
247 Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals Carbo-Bague, Imma
112-113 C p.
 article
248 Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system Wilson, Alan A.
 2017
 112-113 C p. 14-20
7 p.
 article
249 Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac Bailey, Tyler A.
112-113 C p. 28-36
 article
250 Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma Vermeulen, Koen
112-113 C p. 1-11
 article
251 Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer Carlucci, Giuseppe
 2017
 112-113 C p. 9-15
7 p.
 article
252 Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer Jiang, Hao
 2019
 112-113 C p. 36-44
 article
253 Evaluation of [18F]FMTEB in Sprague Dawley rats as a PET tracer for metabotropic glutamate receptor 5 Krzyczmonik, Anna
112-113 C p.
 article
254 Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats Salabert, Anne-Sophie
 2018
 112-113 C p. 1-8
 article
255 Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function Yagi, Yusuke
112-113 C p. 25-31
 article
256 Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine Shalgunov, Vladimir
112-113 C p.
 article
257 Evaluation of heterotopic ossification maturity using SPECT/CT and PET/CT in preclinical model Dannoon, Shorouk
112-113 C p.
 article
258 Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII Fiedler, L.
 2018
 112-113 C p. 55-62
 article
259 Evaluation of N-(6-[18F]Fluoropyridin-3-yl)glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy Wang, Hongliang
112-113 C p. 59-65
 article
260 Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer. Li, Yawen
112-113 C p. 217-227
 article
261 Evaluation of radio-thin-layer chromatography as an alternative to radio-HPLC for [18F]SynVesT-1 metabolism analysis in rats Balayeva, Tutukhanim
112-113 C p.
 article
262 Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging Hu, Mei
112-113 C p.
 article
263 Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents Josefsson, Anders
112-113 C p.
 article
264 Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors Honarvar, Hadis
 2017
 112-113 C p. 15-21
7 p.
 article
265 Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors Abreu Diaz, Aida M.
112-113 C p. 41-49
 article
266 Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs Raval, Nakul Ravi
112-113 C p. 42-48
 article
267 Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA Pretze, Marc
 2017
 112-113 C p. 35-42
8 p.
 article
268 Excitation function and yield for the 103Rh(d,2n)103Pd nuclear reaction: Optimization of the production of palladium-103 Manenti, Simone
 2017
 112-113 C p. 30-37
 article
269 Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging Tang, Caihua
112-113 C p. 55-62
 article
270 EXIRAD-3D: Fast automated three-dimensional autoradiography Nguyen, Minh Phuong
112-113 C p. 59-65
 article
271 Expanding LogP: Present possibilities Vraka, Chrysoula
 2018
 112-113 C p. 20-32
 article
272 Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18 Coenen, Heinz H.
112-113 C p. 241-269
 article
273 Exploration of the utilization of irreversible cysteine protease inhibitor in FAP-targeted radiopharmaceuticals design to increase tumor residence time Brake, Katie
112-113 C p.
 article
274 Facile radiochemical separation of clinical-grade 90Y from 90Sr by selective precipitation for targeted radionuclide therapy Chakravarty, Rubel
 2019
 112-113 C p. 58-65
 article
275 [18F]BCPP-BF-PET as an imaging tool for mitochondrial dysfunction in diabetic pancreatopathy and nephrotoxicity Tomonari, Yuki
112-113 C p.
 article
276 [18F]BCPP-EF positron emission tomography of rat ovaries for evaluation of mitochondrial function Tomonari, Yuki
112-113 C p.
 article
277 Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[18F]fluoropropyl)benzylguanidine ([18F]mFPBG) Woo, Sang-Keun
 2018
 112-113 C p. 63-70
 article
278 Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain Fuchigami, Takeshi
112-113 C p. 41-48
 article
279 [18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model de Paula Faria, Daniele
112-113 C p.
 article
280 [18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease Keller, Thomas
 2018
 112-113 C p. 1-9
 article
281 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation Verhoeven, Jeroen
112-113 C p. 9-16
 article
282 18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury Rodrigues, Rosana S.
 2017
 112-113 C p. 52-62
11 p.
 article
283 [18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response McNeal, Kaytlyn C.
112-113 C p.
 article
284 [18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO Zhou, Weiyan
 2018
 112-113 C p. 45-55
 article
285 First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N 4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115 Chao, Chih-Kai
112-113 C p.
 article
286 18F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer Xu, Duo
 2018
 112-113 C p. 48-55
 article
287 18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer Gao, Fei
 2019
 112-113 C p. 62-69
 article
288 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation Kirjavainen, Anna K.
 2018
 112-113 C p. 39-46
 article
289 18F-Labeled perfluorocarbon droplets for positron emission tomography imaging Amir, Nagina
 2017
 112-113 C p. 27-33
7 p.
 article
290 18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2 Ackermann, Uwe
112-113 C p.
 article
291 18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging Kwon, Young-Do
112-113 C p. 22-36
 article
292 Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain Zhang, Yan
 2018
 112-113 C p. 1-9
 article
293 Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging Demétrio de Souza França, Paula
112-113 C p. 80-87
 article
294 Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate Sundaram, G.S.M.
112-113 C p. 33-40
 article
295 From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience Pouget, Jean-Pierre
112-113 C p. 53-64
 article
296 [18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4 Amor-Coarasa, Alejandro
 2018
 112-113 C p. 37-44
 article
297 Fully automated dual-run manufacturing of [11C]PIB on FASTlab Nair, Manoj
112-113 C p.
 article
298 GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726 Nguyen, Van T.
112-113 C p. 44-51
 article
299 [68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT Kroiss, Alexander Stephan
 2019
 112-113 C p. 47-53
 article
300 68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents Sivapackiam, Jothilingam
 2018
 112-113 C p. 29-35
 article
301 [68Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent Shi, Shengyu
112-113 C p. 17-24
 article
302 [68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging Rivera-Bravo, Belén
112-113 C p. 54-60
 article
303 [68Ga]Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma Zhang, Pengjun
112-113 C p. 19-24
 article
304 67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes Ioppolo, Joseph A.
 2017
 112-113 C p. 32-41
10 p.
 article
305 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics Mittal, Sweety
112-113 C p. 61-67
 article
306 68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma Li, Linlin
112-113 C p. 87-96
 article
307 68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging Chen, Chien-Jen
 2019
 112-113 C p. 22-30
 article
308 Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent Bhatt, Jyotsna
112-113 C p. 47-53
 article
309 Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26 Baun, Christina
112-113 C p.
 article
310 [68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair Nader, M.
112-113 C p. 37-44
 article
311 Gefitinib enhances radiotherapeutic effects of 131I–hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts Xia, Lu
 2017
 112-113 C p. 63-68
6 p.
 article
312 GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study Velikyan, Irina
112-113 C p. 73-85
 article
313 Gold nanoparticles meet medical radionuclides Daems, Noami
112-113 C p. 61-90
 article
314 Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET Andersen, Katrine B.
112-113 C p. 52-58
 article
315 High-throughput radio-TLC analysis Wang, Jia
112-113 C p. 41-48
 article
316 High-yield cyclotron production of 203Pb using a sealed 205Tl solid target Nelson, Bryce J.B.
112-113 C p.
 article
317 HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study Follacchio, Giulia Anna
112-113 C p. 94-100
 article
318 How green are radiopharmaceutical sciences? Pichler, Verena
112-113 C p.
 article
319 HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging Li, Ai-Mei
112-113 C p. 27-34
 article
320 Human biodistribution and dosimetry of [18F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer Betthauser, Tobey J.
 2017
 112-113 C p. 7-11
 article
321 Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine Frisch, Kim
 2019
 112-113 C p. 55-61
 article
322 IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals Jalilian, A.R.
112-113 C p.
 article
323 Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM Igarashi, Chika
112-113 C p. 10-15
 article
324 131I-labeled chitosan hydrogels for radioembolization: A preclinical study in small animals Hwang, Hyosook
 2017
 112-113 C p. 16-23
8 p.
 article
325 Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction Liu, Zhonglin
 2019
 112-113 C p. 67-77
 article
326 Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18F-FEPPA PET Hsieh, Hsin-Hua
112-113 C p.
 article
327 Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution Bongarzone, Salvatore
112-113 C p. 24-33
 article
328 Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model Houson, Hailey A.
 2018
 112-113 C p. 9-15
 article
329 Imaging of microglia in post-stroke inflammation Wang, Ze
112-113 C p.
 article
330 Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids Park, Ji Yong
112-113 C p. 28-35
 article
331 Imaging thrombosis with 99mTc-labeled RAM.1-antibody in vivo Ouadi, Ali
 2018
 112-113 C p. 21-27
 article
332 [131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma Kobayashi, Masato
112-113 C p. 49-54
 article
333 Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides Xu, Dong
 2017
 112-113 C p. 1-8
8 p.
 article
334 Immuno-imaging of ICAM-1 in tumours by SPECT Mosley, Michael
112-113 C p. 73-79
 article
335 Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma Wen, Xuejun
112-113 C p. 44-51
 article
336 Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents Tietz, Ole
112-113 C p. 9-17
 article
337 Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation Ellison, Paul A.
112-113 C p. 32-36
 article
338 Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals Wang, Ivan E.
112-113 C p.
 article
339 Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons Kurakina, E.S.
112-113 C p. 22-27
 article
340 Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging Ruivo, Eduardo
112-113 C p. 36-42
 article
341 Improving metabolic stability of fluorine-18 labeled verapamil analogs Raaphorst, Renske M.
112-113 C p. 47-56
 article
342 111In-DTPA-d-Phe−1-Asp0-d-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-d-Phe1-octreotide Oshima, Nobuhiro
 2017
 112-113 C p. 18-26
9 p.
 article
343 Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor Schneider, Daniela
112-113 C p. 1-8
 article
344 Influence of PEGylation on HER2-targeting retro A9 peptide analogue Yadav, Sushree Arpitabala
112-113 C p.
 article
345 Influence of transport line material on the molar activity of cyclotron produced [18F]fluoride Savisto, Nina
112-113 C p. 8-15
 article
346 Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals Jörg, G.
 2017
 112-113 C p. 105-113
9 p.
 article
347 Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma Giri, Sabeena
112-113 C p.
 article
348 Intraarticular and intravenous administration of 99MTc-HMPAO-labeled human mesenchymal stem cells ( 99M TC-AH-MSC S ): In vivo imaging and biodistribution Meseguer-Olmo, Luis
 2017
 112-113 C p. 36-42
7 p.
 article
349 Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor Khalil, Amina
112-113 C p.
 article
350 Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines Delbart, Wendy
112-113 C p. 68-79
 article
351 Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques Sasaki, Takanori
112-113 C p.
 article
352 Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE Andersen, Ida Vang
112-113 C p.
 article
353 Investigation of 123I production using electron accelerator Avetisyan, Albert
 2017
 112-113 C p. 44-47
 article
354 In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector Läppchen, Tilman
 2018
 112-113 C p. 45-54
 article
355 In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain Kilbourn, Michael R.
112-113 C p. 38-42
 article
356 In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab Othman, Muhamad Faiz bin
112-113 C p. 57-64
 article
357 In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies Varlow, Cassis
112-113 C p.
 article
358 In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate Yamasaki, Kazuaki
 2018
 112-113 C p. 21-25
 article
359 In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model Jiao, Honglei
 2019
 112-113 C p. 31-39
 article
360 In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration Patel, Shil
112-113 C p. 20-30
 article
361 In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4 Renard, Isaline
112-113 C p.
 article
362 Is logP truly dead? Kilbourn, Michael R.
 2017
 112-113 C p. 41-42
2 p.
 article
363 Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibility Kilbourn, Michael R.
 2018
 112-113 C p. 52-55
 article
364 Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals Klenner, Mitchell A.
112-113 C p. 112-147
 article
365 Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713 Yasuno, Fumihiko
112-113 C p. 76-84
 article
366 Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators Hong, Haiyan
112-113 C p. 1-9
 article
367 Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy O'Neill, Edward
112-113 C p. 44-53
 article
368 Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate Zhou, Zhengyuan
112-113 C p. 24-35
 article
369 Laminated holmium-166-containing electrospun bandages for use against skin cancer Osipitan, Ositomiwa O.
112-113 C p. 78-85
 article
370 LogP, a yesterday's value? Vraka, Chrysoula
 2017
 112-113 C p. 1-10
 article
371 Longitudinal multimodal monitoring of transplanted islet β-cells Michelotti, Filippo C.
112-113 C p.
 article
372 Longitudinal multi-tracer imaging of hepatocellular carcinoma identifies novel stage- and oncogene-specific changes Teuter, Mari
112-113 C p.
 article
373 Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of 131I-labeling Wagener, Karolin
 2018
 112-113 C p. 59-66
 article
374 Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer Bandara, Nilantha
112-113 C p. 71-77
 article
375 Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors Kong, Ziren
112-113 C p. 80-87
 article
376 Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides Costa, Ines M.
112-113 C p. 18-29
 article
377 MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons Xu, Yingjiao
112-113 C p. 9-18
 article
378 Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors Lisova, Ksenia
 2018
 112-113 C p. 36-44
 article
379 Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling Gawne, Peter J.
112-113 C p. 6-17
 article
380 Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity Chegu, Anusha
112-113 C p. 70-75
 article
381 Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders Brandt, Marie
 2019
 112-113 C p. 46-52
 article
382 Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands Winter, Gordon
 2019
 112-113 C p. 20-25
 article
383 Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method Pichler, Verena
 2018
 112-113 C p. 21-26
 article
384 Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras Jiao, Yuying
112-113 C p. 28-37
 article
385 Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease Giron, Maria Cecilia
112-113 C p. 72-77
 article
386 Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET Wagner, Michael
 2018
 112-113 C p. 51-58
 article
387 Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system Yoo, Ran Ji
 2017
 112-113 C p. 45-51
7 p.
 article
388 Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: Radiosynthesis and evaluation as potential renal tubular tracers Lipowska, Malgorzata
 2017
 112-113 C p. 48-55
 article
389 [99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference Palmieri, Luca
 2018
 112-113 C p. 1-9
 article
390 99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging Rezazadeh, Farzaneh
112-113 C p. 54-62
 article
391 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients Santos-Cuevas, Clara
 2017
 112-113 C p. 1-6
6 p.
 article
392 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen Xu, Xiaoping
 2017
 112-113 C p. 69-75
7 p.
 article
393 99mTc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn Zhang, Xin
 2017
 112-113 C p. 44-49
 article
394 [99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy Li, Yi
 2018
 112-113 C p. 18-25
 article
395 [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers Vats, Kusum
112-113 C p.
 article
396 [99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas Vallejo-Armenta, Paola
112-113 C p. 1-8
 article
397 Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer Sarparanta, Mirkka
112-113 C p. 1-12
 article
398 NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method Paludan, J.P.
112-113 C p. 1-5
 article
399 Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy Piotrowska, Agata
 2017
 112-113 C p. 10-18
 article
400 Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets Kim, Junghyun
 2017
 112-113 C p. 42-48
7 p.
 article
401 Neutron-activated theranostic radionuclides for nuclear medicine Tan, Hun Yee
112-113 C p. 55-68
 article
402 New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles Moiseeva, A.N.
112-113 C p. 52-61
 article
403 New potent A1 adenosine receptor radioligands for positron emission tomography Kreft, Sabrina
 2017
 112-113 C p. 69-77
9 p.
 article
404 News ways of understanding the complex biology of diabetes using PET Eriksson, O.
112-113 C p. 65-71
 article
405 N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in rats Frisch, Kim
 2018
 112-113 C p. 56-62
 article
406 N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigs Frisch, Kim
112-113 C p. 49-57
 article
407 N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic Schmitt, Sébastien
 2017
 112-113 C p. 50-61
12 p.
 article
408 Nicotinic acetylcholine receptor imaging with [18F]ASEM for skeletal muscle denervation: A novel assessment for peripheral neuromuscular disorders Park, Jae Sung
112-113 C p.
 article
409 Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model Bansal, Aditya
112-113 C p. 4-11
 article
410 Noninvasively visualize the expression of LAPTM4B protein using a novel 18F-labeled peptide PET probe in hepatocellular carcinoma Ren, Yunyan
112-113 C p. 52-60
 article
411 [No title] Gott, Matthew
112-113 C p. 32
 article
412 Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta) Meijer, Lisette
112-113 C p. 1-8
 article
413 Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targets Grundmane, Aivija
112-113 C p.
 article
414 Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers Blevins, David W.
112-113 C p. 41-48
 article
415 Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation Teyssier, Valentin R.
112-113 C p. 34-44
 article
416 Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution Egorova, B.V.
 2018
 112-113 C p. 1-10
 article
417 Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas Watanabe, Hiroyuki
112-113 C p. 93-97
 article
418 Nuclear data for production and medical application of radionuclides: Present status and future needs Qaim, Syed M.
 2017
 112-113 C p. 31-49
19 p.
 article
419 Obituary: P. August Schubiger, PhD (1945–2024) Schibli, Roger
112-113 C p.
 article
420 O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human Imperiale, Alessio
 2017
 112-113 C p. 21-28
8 p.
 article
421 On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling Socan, A.
 2019
 112-113 C p. 23-31
 article
422 One-pot enzymatic synthesis of l-[3-11C]lactate for pharmacokinetic analysis of lactate metabolism in rat brain Temma, Takashi
112-113 C p. 28-33
 article
423 One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging Basuli, Falguni
112-113 C p. 63-70
 article
424 One-step 18F-fluorination of smart positron emission tomography tracer for sensing furin activity in tumors Zhao, Xueyu
112-113 C p. 72-79
 article
425 On the applicability of [18F]FBPA to predict L-BPA concentration after amino acid preloading in HuH-7 liver tumor model and the implication for liver boron neutron capture therapy Grunewald, Catrin
 2017
 112-113 C p. 83-89
7 p.
 article
426 On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion Herth, Matthias M.
112-113 C p. 19-21
 article
427 Optimization of solid-phase extraction (SPE) in the preparation of [18F]D3FSP: A new PET imaging agent for mapping Aβ plaques Yao, Xinyue
 2019
 112-113 C p. 54-64
 article
428 Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine Ohshima, Yasuhiro
112-113 C p. 44-51
 article
429 Outside Back Cover
112-113 C p. OBC
 article
430 Outside Back Cover
112-113 C p. OBC
 article
431 Outside Back Cover
112-113 C p. OBC
 article
432 Outside Back Cover
112-113 C p. OBC
 article
433 Outside Back Cover
112-113 C p. OBC
 article
434 Outside Back Cover
112-113 C p. OBC
 article
435 Outside Back Cover
112-113 C p. OBC
 article
436 Outside Back Cover - Graphical abstract TOC
112-113 C p. OBC
 article
437 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
438 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
439 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
440 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
441 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
442 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
443 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
444 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
445 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
446 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
447 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
448 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
449 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
450 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p. OBC
 article
451 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
452 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
453 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
454 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
455 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
456 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
457 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
458 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
459 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
460 Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
112-113 C p.
 article
461 Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours Geenen, Lorain
112-113 C p. 1-11
 article
462 Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity Seo, Daniele
 2017
 112-113 C p. 57-64
 article
463 Passive and receptor mediated brain delivery of an anti-GFAP nanobody Meier, Silvio R.
112-113 C p. 128-134
 article
464 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models Kasten, Benjamin B.
 2018
 112-113 C p. 67-73
 article
465 Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy Bongarzone, Salvatore
112-113 C p. 66-67
 article
466 PET [11C]acetate is also a perfusion tracer for kidney evaluation purposes Normand, Gabrielle
112-113 C p. 10-14
 article
467 PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients Calabria, Ferdinando
 2017
 112-113 C p. 40-54
15 p.
 article
468 PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs Wong, Patty
 2017
 112-113 C p. 62-68
 article
469 PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model Lin, Jia-zhe
112-113 C p.
 article
470 PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data Tang, Jie
112-113 C p. 1-9
 article
471 PET measurement of “GABA shift” in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil Kim, Wook
 2017
 112-113 C p. 30-34
5 p.
 article
472 PET studies in non-human primates: Choosing drug doses Kilbourn, Michael R.
 2017
 112-113 C p. 1-3
 article
473 Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex Mairinger, Severin
112-113 C p. 28-32
 article
474 p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide H.A. Kankanamalage, Pavithra
112-113 C p. 1-9
 article
475 Potent candidates for Targeted Alpha Therapy (TAT) Filosofov, Dmitry
112-113 C p.
 article
476 Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations Filosofov, Dmitry
112-113 C p. 1-19
 article
477 Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb Fiaccabrino, Desiree Erika
112-113 C p. 81-91
 article
478 Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors Ingham, Aidan
112-113 C p.
 article
479 Preclinical evaluation of [225Ac]Ac-PSMA-617 and in vivo effect comparison in combination with [177Lu]Lu-PSMA-617 for prostate cancer Savio, E.
112-113 C p.
 article
480 Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase Estrada, Sergio
112-113 C p. 62-71
 article
481 Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model Lien, Vegard Torp
112-113 C p. 74-80
 article
482 Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain Zha, Zhihao
112-113 C p. 97-106
 article
483 Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci Petrosova, Kristina A.
112-113 C p.
 article
484 Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats Matsusaka, Yohji
 2018
 112-113 C p. 26-30
 article
485 Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice Aghevlian, Sadaf
112-113 C p. 8-17
 article
486 Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH Wharton, Luke
112-113 C p.
 article
487 Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model Ohshima, Yasuhiro
112-113 C p. 15-22
 article
488 Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis Higashikawa, Kei
112-113 C p. 25-32
 article
489 Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical Courault, Pierre
112-113 C p.
 article
490 Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2 Wichmann, Christian Werner
112-113 C p.
 article
491 Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer Hoffman, S.L.V.
112-113 C p.
 article
492 Preclinical study of an 18F-labeled glutamine derivative for cancer imaging Li, Cong
112-113 C p. 34-40
 article
493 Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue Emery, Stéphane
112-113 C p. 57-63
 article
494 Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155 Mitsuoka, Keisuke
112-113 C p. 41-46
 article
495 Preferred use of curie (ci) rather than becquerel (Bq) in nuclear medicine practice Pillai, Maroor Raghavan Ambikalmajan
 2017
 112-113 C p. 51-52
2 p.
 article
496 Pre-labelling versus direct labelling of anthrax proteins for imaging of matrix metalloproteinases activity using DOTA-GA Xavier, Mary-Ann Elvina
 2019
 112-113 C p. 49-54
 article
497 Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer Zhou, Dong
 2018
 112-113 C p. 26-31
 article
498 Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma Roxin, Áron
 2018
 112-113 C p. 11-20
 article
499 Preoperative [18F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study Ciggaar, Isabeau A.
112-113 C p.
 article
500 Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab Azadbakht, Bakhtiar
 2017
 112-113 C p. 26-30
5 p.
 article
501 Preparation and evaluation of 111In-labeled liposomes containing phosphatidylglycerol for detection of macrophages in atherosclerotic plaques Munekane, Masayuki
112-113 C p.
 article
502 Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases Tang, Tang
 2017
 112-113 C p. 10-17
8 p.
 article
503 Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis Erfani, Mostafa
 2017
 112-113 C p. 1-7
 article
504 Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb Jakobsson, Ulrika
112-113 C p. 102-110
 article
505 Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen Drescher, Robert
112-113 C p.
 article
506 Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate Lee, Ji Youn
112-113 C p. 38-45
 article
507 Preparation of [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies Guleria, Mohini
112-113 C p. 31-40
 article
508 Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution Westrøm, Sara
 2017
 112-113 C p. 1-9
9 p.
 article
509 Production and purification of radiolabeling-ready 132/135La from the irradiation of metallic natBa targets with low energy protons Kurakina, E.S.
112-113 C p.
 article
510 Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb Kostelnik, Thomas I.
112-113 C p.
 article
511 Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply McIntosh, Lauren A.
112-113 C p.
 article
512 Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography Chen, Junyi
112-113 C p. 54-60
 article
513 Production of Zr-89 using sputtered yttrium coin targets Queern, Stacy Lee
 2017
 112-113 C p. 11-16
 article
514 Production, purification and availability of 211At: Near term steps towards global access Feng, Yutian
112-113 C p. 12-23
 article
515 Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy Ghosh, Sanchita
112-113 C p.
 article
516 Professor Jon Dilworth: Shining a Light on the Chemistry of Metals Used in Biology, Medicine and Radiochemistry Dilworth, Jonathan R.
112-113 C p.
 article
517 Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine Schillaci, Orazio
 2019
 112-113 C p. 66-79
 article
518 Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development Radchenko, Valery
 2017
 112-113 C p. 25-32
 article
519 PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics Huynh, Truc T.
112-113 C p.
 article
520 Publisher’s note
112-113 C p.
 article
521 Quantitation of rat cerebral blood flow using 99mTc-HMPAO Suzuki, Chie
 2017
 112-113 C p. 19-22
 article
522 Quantitative imaging using [18F]F-TZ3108 to assess metabolic-associated fatty liver disease progression and low-carbohydrate diet efficacy Han, Zongping
112-113 C p.
 article
523 Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody Nakata, Norihito
112-113 C p. 33-43
 article
524 Radiation dosimetry of [18F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolism Lee, Narae
 2019
 112-113 C p. 45-48
 article
525 Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans Tournier, Benjamin B.
112-113 C p.
 article
526 Radiation induced oxidation of [18F]fluorothia fatty acids under cGMP manufacturing conditions Pandey, Mukesh K.
112-113 C p. 13-23
 article
527 Radioarsenic: A promising theragnostic candidate for nuclear medicine Sanders, Vanessa A.
112-113 C p. 184-201
 article
528 Radiobiological effect of alpha particles. The scientific basis of targeted alpha-particle therapy Cruz-Nova, Pedro
112-113 C p.
 article
529 Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma Sobral, Danielle V.
112-113 C p. 14-23
 article
530 Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+ Hierlmeier, Ina
112-113 C p.
 article
531 Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib Boyle, Amanda J.
112-113 C p. 46-54
 article
532 Radiolabeling and biological characterization of TPGS-based nanomicelles by means of small animal imaging Tesan, Fiorella Carla
 2017
 112-113 C p. 62-68
7 p.
 article
533 Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu Shalgunov, Vladimir
112-113 C p. 11-21
 article
534 Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results Imura, Ryota
112-113 C p. 21-28
 article
535 Radiolabeling with [11C]HCN for Positron emission tomography Zhou, Yu-Peng
112-113 C p. 56-86
 article
536 Radiolabeling yield dependency of post-dry distillation decay of astatine-211 Hansson, Ellinor
112-113 C p.
 article
537 Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1 Rosestedt, Maria
112-113 C p. 54-62
 article
538 Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy Nelson, Bryce J.B.
112-113 C p. 59-66
 article
539 Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles Pozzi, Oscar R.
 2017
 112-113 C p. 43-49
7 p.
 article
540 Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation Nemieboka, Brandon
112-113 C p. 9-19
 article
541 Radiopharmacy in Africa: current status and future directions Ekoume, F.P.
112-113 C p. 29-33
 article
542 Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging Tang, Caihua
 2017
 112-113 C p. 39-46
 article
543 Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1 Huang, Tianyu
112-113 C p. 18-27
 article
544 Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands Willmann, Michael
112-113 C p. 43-52
 article
545 Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging Wang, Hongliang
112-113 C p. 98-105
 article
546 Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer Jackson, Isaac M.
112-113 C p. 143-150
 article
547 Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins Bai, Ping
112-113 C p. 96-101
 article
548 Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine Baguet, Tristan
112-113 C p. 20-29
 article
549 Rapid and automated production of [68Ga]gallium chloride and [68Ga]Ga-DOTA-TATE on a medical cyclotron Tieu, William
112-113 C p. 12-18
 article
550 Rapid detection of SARS-CoV-2 using a radiolabeled antibody Pirovano, Giacomo
112-113 C p. 69-75
 article
551 Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application Bamminger, Karsten
112-113 C p. 189-197
 article
552 Reactive oxygen species-driven HIF1α triggers accelerated glycolysis in endothelial cells exposed to low oxygen tension Paik, Jin-Young
 2017
 112-113 C p. 8-14
7 p.
 article
553 Re-assessing gallium-67 as a therapeutic radionuclide Othman, Muhamad F. bin
 2017
 112-113 C p. 12-18
7 p.
 article
554 Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals Piron, Sarah
112-113 C p. 29-51
 article
555 Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation Lipowska, Malgorzata
 2018
 112-113 C p. 42-50
 article
556 Reconsider logP! Vraka, Chrysoula
 2017
 112-113 C p. 42-
1 p.
 article
557 Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity Oshima, Nobuhiro
 2017
 112-113 C p. 16-25
10 p.
 article
558 Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes Suzuki, Hiroyuki
112-113 C p.
 article
559 Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO Nakajima, Kohei
112-113 C p. 85-92
 article
560 Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18F]FBEM and in vivo PET studies Dammicco, Sylvestre
 2017
 112-113 C p. 33-39
7 p.
 article
561 Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake Kagawa, Shinya
 2017
 112-113 C p. 8-15
 article
562 Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells Boyle, Amanda J.
112-113 C p.
 article
563 Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides Arano, Yasushi
112-113 C p. 149-155
 article
564 Repeatability of brown adipose tissue activation measured by [18F]FDG PET after beta3-adrenergic stimuli in a mouse model de Paula Faria, Daniele
112-113 C p.
 article
565 RETRACTED: Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors Sun, Penghui
112-113 C p. 1-9
 article
566 Review on 99mTc radiopharmaceuticals with emphasis on new advancements Duatti, Adriano
112-113 C p. 202-216
 article
567 Review: PET imaging with macro- and middle-sized molecular probes Mukai, Hidefumi
112-113 C p. 156-170
 article
568 Robust high-yield ~1 TBq production of cyclotron based sodium [99mTc]pertechnetate Andersson, J.D.
 2018
 112-113 C p. 63-70
 article
569 Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy Xu, Qinfeng
112-113 C p. 34-43
 article
570 Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging Spahn, Muriel Aline
112-113 C p.
 article
571 Semi-automated system for concentrating 68Ga-eluate to obtain high molar and volume concentration of 68Ga-Radiopharmaca for preclinical applications de Blois, Erik
112-113 C p. 16-21
 article
572 Serotonin transporter imaging agent as a probe for β-cells of pancreas Sun, Yuli
112-113 C p.
 article
573 Sex-differences in [68Ga]Ga-DOTANOC biodistribution Leisser, A.
112-113 C p. 15-20
 article
574 Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer Sun, Aixia
 2017
 112-113 C p. 38-43
 article
575 Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia – Multimodal imaging assessment Goggi, Julian Luke
 2017
 112-113 C p. 25-31
7 p.
 article
576 Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent Feng, Yutian
112-113 C p. 171-183
 article
577 Small-scale production of 67Cu for a preclinical study via the 64Ni(α, p)67Cu channel Ohya, Tomoyuki
 2018
 112-113 C p. 56-60
 article
578 Solid phase extraction chromatography-based radiochemical isolation of cyclotron-produced 51Mn from enriched 54Fe targets Barrett, Kendall E.
112-113 C p.
 article
579 Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression Xu, Jinbin
112-113 C p. 65-70
 article
580 Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes Makris, George
 2019
 112-113 C p. 39-46
 article
581 Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers Nics, Lukas
 2018
 112-113 C p. 28-33
 article
582 Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy Radchenko, Valery
112-113 C p. 106
 article
583 Status of radiobiology in molecular radionuclide therapy – Hope for the future Nonnekens, Julie
112-113 C p. 45-46
 article
584 Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative Coenen, Heinz H.
 2019
 112-113 C p. 19-22
 article
585 Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders Yamaguchi, Keisei
112-113 C p.
 article
586 Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt Madumarov, Alexander S.
112-113 C p.
 article
587 Synthesis and characterization of 64Cu-labeled Geldanamycin derivative for imaging HSP90 expression in breast cancer Li, Feng
112-113 C p.
 article
588 Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2 Luo, Zonghua
112-113 C p. 52-61
 article
589 Synthesis and evaluation of a 68Ga-labeled spermine derivative for tumor PET imaging Qin, Kaixin
112-113 C p.
 article
590 Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors Mikaeili, Azadeh
 2017
 112-113 C p. 10-17
8 p.
 article
591 Synthesis and evaluation of a 99mTc-labelled deuterated tropane derivative as a SPECT probe for dopamine transporter Kang, Jing
112-113 C p.
 article
592 Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors Radford, Lauren
 2017
 112-113 C p. 4-9
 article
593 Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone Hirata, Saki
112-113 C p. 34-41
 article
594 Synthesis and evaluation of an N-[18F]fluorodeoxyglycosyl amino acid for PET imaging of tumor metabolism Wu, Zhifang
 2018
 112-113 C p. 40-48
 article
595 Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor Zha, Zhihao
 2018
 112-113 C p. 36-47
 article
596 Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides Suzuki, Hiroyuki
112-113 C p. 18-28
 article
597 Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia Pees, Anna
112-113 C p. 97-105
 article
598 Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO) Qiao, Zheng
112-113 C p. 1-10
 article
599 Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging Li, Xueli
112-113 C p. 84-92
 article
600 Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX Nakashima, Kazuma
112-113 C p. 46-53
 article
601 Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter Das, Soumen
 2019
 112-113 C p. 49-57
 article
602 Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting Paparidis, Georgios
 2018
 112-113 C p. 34-41
 article
603 Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation Tsuchihashi, Shohei
112-113 C p.
 article
604 Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease Lerdsirisuk, Pradith
112-113 C p. 11-18
 article
605 Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors Lindberg, Anton
 2019
 112-113 C p. 1-13
 article
606 Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging Jacobsen, Christian Borch
112-113 C p. 49-56
 article
607 Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics Lambidis, Elisavet
112-113 C p. 151-161
 article
608 Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer Kwan, Kim H.
112-113 C p. 37-45
 article
609 Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5 Rotteveel, Lonneke
112-113 C p. 9-19
 article
610 Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages Fernandes, Bruna
112-113 C p.
 article
611 Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass Eriksson, Jonas
 2019
 112-113 C p. 1-10
 article
612 Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor Högnäsbacka, Antonia
112-113 C p.
 article
613 Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer Vaidyanathan, Ganesan
112-113 C p. 67-80
 article
614 Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides Sanders, Vanessa A.
 2019
 112-113 C p. 1-13
 article
615 Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors Prause, Martin
 2018
 112-113 C p. 1-11
 article
616 Synthesis of 11C-labeled DNA polymerase-β inhibitor 5-methoxyflavone and PET/CT imaging thereof Chen, Zude
112-113 C p. 17-22
 article
617 Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors Arisawa, Tetsu
112-113 C p. 47-58
 article
618 Synthesis of N-(6-[18F]Fluoropyridin-3-yl)glycine as a potential renal PET agent Wang, Hongliang
112-113 C p. 21-27
 article
619 Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor Klein, Pieter J.
 2017
 112-113 C p. 25-32
8 p.
 article
620 Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds Wanek, Thomas
112-113 C p.
 article
621 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
622 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
623 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
624 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
625 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
626 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
627 Table of Contents 2018
 112-113 C p. IBC
 article
628 Table of Contents
112-113 C p. IBC
 article
629 Table of Contents
112-113 C p. IBC
 article
630 Table of Contents 2018
 112-113 C p. IBC
 article
631 Table of Contents 2017
 112-113 C p. IBC
 article
632 Table of Contents 2018
 112-113 C p. IBC
 article
633 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
634 Table of Contents 2017
 112-113 C p. IBC-
1 p.
 article
635 Table of Contents 2017
 112-113 C p. IBC
 article
636 Table of Contents 2017
 112-113 C p. IBC
 article
637 Table of Contents 2017
 112-113 C p. IBC
 article
638 Table Of Contents 2018
 112-113 C p. IBC
 article
639 Table of Contents 2018
 112-113 C p. IBC
 article
640 Table of Contents 2018
 112-113 C p. IBC
 article
641 Table of Contents & Barcode 2018
 112-113 C p. IBC
 article
642 Table of Contents & Barcode 2018
 112-113 C p. IBC
 article
643 Tactics for preclinical validation of receptor-binding radiotracers Lever, Susan Z.
 2017
 112-113 C p. 4-30
27 p.
 article
644 Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers Nelson, Bryce J.B.
112-113 C p. 24-31
 article
645 Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals Rigby, Alex
112-113 C p. 1-7
 article
646 Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy Magro, Natalia
112-113 C p.
 article
647 Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer Li, Junling
112-113 C p. 23-30
 article
648 Target manufacturing by Spark Plasma Sintering for efficient 89Zr production Cisternino, S.
112-113 C p. 38-46
 article
649 Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177 Trejtnar, František
112-113 C p.
 article
650 The development of 11C-carbonylation chemistry: A systematic view Eriksson, Jonas
112-113 C p. 115-137
 article
651 The effect of hypoxia on the induction of strand breaks in plasmid DNA by alpha-, beta- and Auger electron-emitters 223Ra, 188Re, 99mTc and DNA-binding 99mTc-labeled pyrene Reissig, Falco
112-113 C p. 65-70
 article
652 The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging Currie, Geoffrey M.
112-113 C p.
 article
653 The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy Aloj, Luigi
112-113 C p. 53-64
 article
654 The future of the radiopharmaceutical sciences Lapi, Suzanne E.
112-113 C p.
 article
655 The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates Jiang, Wen
112-113 C p. 1-8
 article
656 The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence Reissig, Falco
112-113 C p. 59-68
 article
657 The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells Raitanen, Julia
112-113 C p.
 article
658 The past, present, and the promise of the future of nuclear medicine and biology Eckelman, W.C.
 2017
 112-113 C p. 47-48
 article
659 The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review Katzenellenbogen, John A.
112-113 C p. 24-37
 article
660 Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry Lin, Wilson
112-113 C p.
 article
661 Theranostic nanoparticles: Investigation of superparamagnetic iron oxide nanoparticles intrinsically labeled with Zirconium-89 and Actinium-225 Diehl, George
112-113 C p.
 article
662 The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far Heynickx, Nathalie
112-113 C p. 30-39
 article
663 Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy Spetz, Johan
 2018
 112-113 C p. 11-18
 article
664 45Ti targeted tracers for PET imaging of PSMA Chaple, Ivis F.
112-113 C p. 16-23
 article
665 Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead Lustenberger, Severin K.
112-113 C p.
 article
666 Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies Driver, Cathryn Helena Stanford
112-113 C p. 53-66
 article
667 Tracer development for PET imaging of proteinopathies Kallinen, Annukka
112-113 C p. 115-127
 article
668 Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography Kirby, Alexia
112-113 C p.
 article
669 Training the next generation of radiopharmaceutical scientists Gee, Antony D.
112-113 C p. 10-13
 article
670 Transcatheter pseudo-vascular isolation for localization and concentration of a large molecule theranostic probe into a transgenic OncoPIG kidney tumor Rice, Samuel L.
112-113 C p.
 article
671 Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus Yokoyama, Yuka
112-113 C p.
 article
672 Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells Kobayashi, Masato
112-113 C p. 33-37
 article
673 Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties Obata, Honoka
112-113 C p.
 article
674 Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1 Al-saden, Noor
 2018
 112-113 C p. 43-51
 article
675 Ubiquicidin derived peptides for infection imaging Sachdeva, Anoushka
112-113 C p.
 article
676 Unexpected decrease in in vivo binding of [3H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [11C]NMPB Inoue, Osamu
 2018
 112-113 C p. 15-20
 article
677 Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage Suzuki, Motofumi
112-113 C p. 45-55
 article
678 Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome Zhao, Fangyuan
112-113 C p. 86-98
 article
679 Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease De Lombaerde, Stef
 2019
 112-113 C p. 40-48
 article
680 Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy Verger, Elise
112-113 C p. 36-43
 article
681 Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer Oh, Sera
112-113 C p. 135-142
 article
682 Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer Xi, Yun
112-113 C p.
 article
683 VMAT2 imaging agent, D6-[18F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization Zhao, Ruiyue
 2019
 112-113 C p. 26-35
 article
684 VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation Tripathi, Sushil K.
 2017
 112-113 C p. 55-61
7 p.
 article
685 What about α v β 3 integrins in molecular imaging in oncology? Debordeaux, Frederic
112-113 C p. 31-46
 article
686 Whole-body biodistribution of the cannabinoid type 1 receptor ligand [18F]MK-9470 in the rat Buchholz, H.G.
 2017
 112-113 C p. 63-69
7 p.
 article
687 William C. Eckelman: An anchor of stability with a quiet voice that nurtured a new field Katzenellenbogen, John A.
112-113 C p. 2-4
 article
688 William C. Eckelman, an icon of radiopharmaceutical sciences Windhorst, A.D.
112-113 C p. 1
 article
689 Women in radiopharmaceutical/radiochemical sciences Choe, Yearn Seong
112-113 C p. 108-114
 article
690 90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres Nezami, Nariman
 2018
 112-113 C p. 22-28
 article
691 89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production Dias, Gemma M.
 2018
 112-113 C p. 1-7
 article
692 [89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors Lyashchenko, Serge K.
112-113 C p.
 article
693 [89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure Bansal, Aditya
112-113 C p. 23-30
 article
                             693 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands